Researchers at the HUN-REN Biological Research Centre have discovered that specific bacteriophages use molecular anchor proteins to attach to and enter human cells, a finding that could transform how scientists design targeted therapeutic delivery systems. By engineering phages to carry these proteins, the team successfully increased their retention time in the mouse gastrointestinal tract, according to a study led by the Bálint Kintses lab.
How do phages interact with human cells?
Phages are traditionally recognized as viruses that exclusively infect bacteria, but new research indicates they can engage with human tissues through specialized surface proteins. According to co-first author Gábor Apjok, these molecular anchors allow phages to bind to human cells and enter them, even though they cannot replicate within human biological systems. Microscopy analysis revealed that these phages travel to the Golgi apparatus and the endoplasmic reticulum. Unlike traditional uptake pathways that lead to cell degradation via lysosomes, these pathways appear to keep the phages intact, suggesting a potential “scenic route” for future medical applications.
The human gut is one of the most virus-rich environments in the body, functioning as a complex ecosystem where phages must navigate mucus, bacteria, and host cells to survive.
What does this mean for the future of phage therapy?
The ability to control phage attachment could solve a primary hurdle in current microbiome medicine: retention. For a therapeutic phage to successfully eliminate a target bacterium, it must remain at the infection site for a sufficient duration. Tóbiás Sári, co-first author of the study, notes that the identification of these surface proteins provides a blueprint for designing phages that can persist in the gut environment. By engineering these “anchors,” scientists may eventually develop treatments that deliver drugs or antimicrobial agents with higher precision than current methods allow.
How does this change our understanding of the gut microbiome?
This research shifts the perspective on the gut virome from a passive collection of viruses to a dynamic system that interacts directly with the human epithelial surface. While previous models focused primarily on phage-bacterial competition, these findings suggest that the human body acts as a host-like environment for these viruses. According to the research team at HUN-REN, this interaction is an evolutionarily advantageous strategy rather than a biological accident, providing phages with a mechanism to persist in a competitive microbial landscape.
When researching microbiome health, look for studies that distinguish between transient and resident phage populations, as this differentiation is key to understanding long-term therapeutic efficacy.
Frequently Asked Questions
Can phages infect human cells like a human virus?
No. According to the HUN-REN study, phages are not human viruses and lack the biological machinery to replicate within human cells.
Why is the Golgi apparatus significant?
The Golgi apparatus and endoplasmic reticulum are essential organelles involved in cell function. Their role in this study suggests that phages may be able to reach specific cellular compartments without being destroyed by the cell’s internal waste-disposal systems.
How were the phages engineered to bind better?
Researchers used genetic engineering to transfer identified adhesion proteins from one phage to another, resulting in higher binding efficiency and longer retention times in mouse models.
What are your thoughts on the future of phage-based medicine? Join the conversation in the comments below or subscribe to our newsletter for the latest updates on microbiome research and synthetic biology.